3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

After first melanoma, a second is quite common

CancerOct 05, 05

Some people with melanoma are at increased risk of developing the skin cancer again in the future, especially if they have a family history of the disease, say researchers at Memorial Sloan Kettering Cancer Center in New York.

But second melanomas, if caught early, are easily cured, said Dr. Daniel G. Coit. “The first melanoma is kind of the wake-up call, the second melanoma becomes very much of a curable thing.”

“The message to the public really is that if you have a melanoma, be on the lookout for a second one,” he said. This means, he advised, performing regular self-exams and going to the dermatologist regularly for a skin check.

Coit and his colleagues conducted their study, published this week in the Journal of the American Medical Association, to investigate risk factors for developing a second melanoma. They followed 4,484 patients diagnosed with melanoma at Memorial Sloan Kettering between 1996 and 2002.

Nearly 9 percent of the patients developed another melanoma, with the greatest risk seen in the first few years after being diagnosed with the original tumor.

Patients with a family history of melanoma had a 19 percent risk of developing a second tumor within five years. The five-year risk for a second melanoma among patients with large moles known as dysplastic nevi—which do not necessarily develop into melanoma but are markers for higher risk—was 24 percent.

Patients who had both dysplastic nevi and a family history of melanoma had a nearly 30 percent risk of developing a second melanoma within five years.

Among patients treated for a second primary melanoma, almost 16 percent developed a third melanoma within one year, while the total risk at five years was 31 percent.

The findings underscore the importance of regular follow-up for patients after melanoma diagnosis and treatment, Coit said. “Our deal here is that the exam is really painless to patients and it’s not like a colonoscopy or mammography or a prostate check,” he said. “This is pretty easy, this is just looking at your skin.”

SOURCE: Journal of the American Medical Association, October 5, 2005.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site